Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow.
作者信息
Ndrepepa Gjin
机构信息
Department of Adult Cardiology, Deutsches Herzzentrum München, Technical University, Munich, Germany.
出版信息
Indian J Med Res. 2017 Sep;146(3):293-297. doi: 10.4103/ijmr.IJMR_1668_17.
Abstract
摘要
相似文献
1
Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow.动脉粥样硬化与缺血性心脏病：长存还是明日即逝。
Indian J Med Res. 2017 Sep;146(3):293-297. doi: 10.4103/ijmr.IJMR_1668_17.
2
About ischaemic heart disease in inflammatory bowel disease: some considerations.
Gut. 2013 May;62(5):800. doi: 10.1136/gutjnl-2012-303985. Epub 2013 Jan 7.
3
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.黄色瘤、角膜弓、缺血性血管疾病与普通人群的死亡：前瞻性队列研究。
BMJ. 2011 Sep 15;343:d5497. doi: 10.1136/bmj.d5497.
4
Ischaemic heart disease in Africa. How common is it? Will it become more common?非洲的缺血性心脏病。它有多常见？它会变得更常见吗？
Heart. 2008 Jul;94(7):824-5. doi: 10.1136/hrt.2008.142778.
5
Cardiovascular risk in inflammatory bowel disease: it's a heartache!炎症性肠病中的心血管风险：令人心痛！
Gastroenterology. 2013 Dec;145(6):1484-6. doi: 10.1053/j.gastro.2013.10.030.
6
Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.自身抗体作为缺血性、扩张性和节律性心脏病可能的标志物和介质。
Curr Drug Targets. 2015;16(4):342-60. doi: 10.2174/1389450115666141125122416.
7
The challenge of blood pressure control in patients with ischaemic heart disease in Europe.
Blood Press Suppl. 2005 Dec;2:6-9.
8
Scientists on the Spot: from the Scientists of Tomorrow to the scientist of today.
Cardiovasc Res. 2020 Nov 1;116(13):e184-e185. doi: 10.1093/cvr/cvaa277.
9
Adapting treatments for adaptive immunity in ischaemic heart disease.
Cardiovasc Res. 2022 Jul 20;118(9):e66-e68. doi: 10.1093/cvr/cvac074.
10
AAV-mediated gene therapy for atherosclerosis.腺相关病毒介导的动脉粥样硬化基因治疗。
Curr Atheroscler Rep. 2014 Sep;16(9):434. doi: 10.1007/s11883-014-0434-0.
引用本文的文献
1
Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs.动脉粥样硬化药物递送的进展：研究用于不同类型药物的不同纳米材料的效率。
Mater Today Bio. 2023 Aug 7;22:100767. doi: 10.1016/j.mtbio.2023.100767. eCollection 2023 Oct.
2
Association between Influenza and COVID-19 Viruses and the Risk of Atherosclerosis: Meta-Analysis Study and Systematic Review.流感和 COVID-19 病毒与动脉粥样硬化风险的关联：荟萃分析研究和系统评价。
Adv Respir Med. 2022 Aug 12;90(4):338-348. doi: 10.3390/arm90040043.
本文引用的文献
1
20-Year Trend of CVD Risk Factors: Urban and Rural National Capital Region of India.20 年 CVD 危险因素变化趋势：印度首都城乡地区。
Glob Heart. 2017 Sep;12(3):209-217. doi: 10.1016/j.gheart.2016.11.004. Epub 2017 Apr 11.
2
Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence.可改变风险因素与冠心病发病率之间关联的时间变化
JAMA. 2016 Nov 15;316(19):2041-2043. doi: 10.1001/jama.2016.13614.
3
Changing trends in the prevalence of coronary heart disease.冠心病患病率的变化趋势
Indian Heart J. 2016 Jul-Aug;68(4):445-6. doi: 10.1016/j.ihj.2016.04.008. Epub 2016 Apr 28.
4
Trends in Coronary Heart Disease Epidemiology in India.印度冠心病流行病学趋势。
Ann Glob Health. 2016 Mar-Apr;82(2):307-15. doi: 10.1016/j.aogh.2016.04.002.
5
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.动脉粥样硬化的流行病学和减少全球动脉粥样血栓疾病负担的潜力。
Circ Res. 2016 Feb 19;118(4):535-46. doi: 10.1161/CIRCRESAHA.115.307611.
6
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study.1990 - 2013年全球缺血性和出血性卒中负担最新情况：全球疾病负担研究2013。
Neuroepidemiology. 2015;45(3):161-76. doi: 10.1159/000441085. Epub 2015 Oct 28.
7
Global and regional patterns in cardiovascular mortality from 1990 to 2013.1990 年至 2013 年全球和各区域心血管疾病死亡率模式。
Circulation. 2015 Oct 27;132(17):1667-78. doi: 10.1161/CIRCULATIONAHA.114.008720.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年：全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.
9
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future.PCSK9（前蛋白转化酶枯草溶菌素 9）抑制剂：过去、现在和未来。
Eur Heart J. 2015 Sep 21;36(36):2415-24. doi: 10.1093/eurheartj/ehv174. Epub 2015 May 12.
10
Atherosclerosis: a longue durée approach.
Glob Heart. 2014 Jun;9(2):239-44. doi: 10.1016/j.gheart.2014.02.002.
Zotero 插件